Drugs / Endotoxin, Escherichia Coli
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04263454 | Mar 2020 → Dec 2021 | fibromyalgia | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Endotoxin, Escherichia Coli | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04263454 ↗ |
| Route | Intravenous | “A low dose of endotoxin (0.3ng/kg) will then be administered by the study nurse via intravenous infusion.” NCT04263454 ↗ |